|
|
|
| The Clinical Efficacy Analysis of Combining Anlotinib with Gefitinib as A First-line Treatment for EGFR-positive Advanced Non-small Cell Lung Cancer |
| LIU Weixuan, WANG Xin, LOU Zhi, JI Yajun |
| First-author's address: Department of Oncology, the First People's Hospital of Lianyungang, Jinzhou Medical University Postgraduate Training Base, Lianyungang 222000, China |
|
|
|
|
|
|
Received: 06 November 2023
|
|
|
|
|
|
|
